Biora Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.104 million compared to USD 0.463 million a year ago. Net loss was USD 5.51 million compared to USD 78.53 million a year ago. Basic loss per share from continuing operations was USD 0.75 compared to USD 16.25 a year ago. Basic loss per share was USD 0.75 compared to USD 30.75 a year ago.
For the six months, sales was USD 0.211 million compared to USD 0.63 million a year ago. Net loss was USD 19.32 million compared to USD 110.8 million a year ago. Basic loss per share from continuing operations was USD 2.75 compared to USD 24.25 a year ago. Basic loss per share was USD 2.5 compared to USD 45.5 a year ago.